Kane Biotech Inc. logo

Kane Biotech Inc. (KNE)

Market Closed
12 Dec, 20:00
TSX-V TSX-V
CA$
0. 04
-0
-12.5%
CA$
16.48M Market Cap
- P/E Ratio
0% Div Yield
167,900 Volume
0 Eps
CA$ 0.04
Previous Close
Day Range
0.04 0.04
Year Range
0.03 0.12
Want to track KNE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

KNE closed Friday lower at CA$0.04, a decrease of 12.5% from Thursday's close, completing a monthly increase of 16.67% or CA$0.01. Over the past 12 months, KNE stock lost -68.18%.
KNE is not paying dividends to its shareholders.
The last earnings report, released on Dec 04, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Kane Biotech Inc. has completed 1 stock splits, with the recent split occurring on Mar 13, 2017.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on TSX-V (CAD).

KNE Chart

Similar

Conavi Medical Corp.
CA$ 0.49
+2.08%
ASG
Aurora Spine Corporation
CA$ 0.28
+1.85%
VPT
Ventripoint Diagnostics Ltd.
CA$ 0.1
-4.76%
GSD
Devonian Health Group Inc.
CA$ 0.19
0%
Zenith Capital Corporation
CA$ 0.1
0%

Kane Biotech Inc. (KNE) FAQ

What is the stock price today?

The current price is CA$0.04.

On which exchange is it traded?

Kane Biotech Inc. is listed on TSX-V.

What is its stock symbol?

The ticker symbol is KNE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 16.48M.

Has Kane Biotech Inc. ever had a stock split?

Kane Biotech Inc. had 1 splits and the recent split was on Mar 13, 2017.

Kane Biotech Inc. Profile

Biotechnology Industry
Healthcare Sector
Dr. Robert B. Huizinga CNeph(C), M.Sc., MSc(Epi), Ph.D., R.N., RN NNC CEO
TSX-V Exchange
CA4838092084 ISIN
CA Country
- Employees
- Last Dividend
13 Mar 2017 Last Split
- IPO Date

Overview

Kane Biotech Inc. is a pioneering biotechnology company that specializes in the discovery, development, and delivery of innovative solutions to combat microbial biofilms. Established in 2001 and headquartered in Winnipeg, Canada, Kane Biotech has established itself as a leader in the biofilm research field, extending its reach both nationally and internationally. The company aims to address the challenges posed by biofilms across a variety of industries, including pet oral care, wound care for animals and humans, and scalp care. Through dedicated research and development efforts, Kane Biotech has successfully translated scientific discoveries into commercial products that tackle biofilm-related issues in practical, effective ways.

Products and Services

  • StrixNB and bluestem: These brands represent Kane Biotech's entry into the pet oral care market, offering products formulated to prevent the formation and help remove microbial biofilms. These products aim to improve oral health in pets, reducing the risk of plaque buildup and gum disease.
  • DispersinB: Under the DispersinB name, Kane Biotech offers both animal and human wound care solutions. The product focuses on the dispersion and removal of biofilms in wound sites, thus promoting faster and more effective healing.
  • DermaKB: This brand focuses on scalp care, with products designed to alleviate various scalp conditions by targeting and eliminating microbial biofilms. The line aims to provide relief for those suffering from dandruff, seborrheic dermatitis, and other scalp issues through innovative biofilm-disruption technologies.
  • Coactiv+: The wound care solutions offered under the Coactiv+ brand are designed for both animal and human applications. These products utilize bioactive compounds to disrupt biofilms and facilitate wound healing, showcasing Kane Biotech’s commitment to advancing wound care treatments.
  • Additional Products: Beyond these flagship brands, Kane Biotech has developed a range of other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm names. Each brand focuses on leveraging biofilm-disrupting technology to address specific health and wellness concerns, further demonstrating the company’s versatility and innovative approach to product development.

Contact Information

Address: 290-100 Innovation Drive
Phone: 204-453-1301